| 6.1 |
18.3 |
GO:0060745 |
mammary gland branching involved in pregnancy(GO:0060745) |
| 6.0 |
18.1 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 5.7 |
17.0 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
| 4.6 |
13.8 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) renal vesicle induction(GO:0072034) |
| 3.4 |
13.4 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
| 3.1 |
12.6 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 3.1 |
9.2 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 2.9 |
20.6 |
GO:0072539 |
T-helper 17 cell differentiation(GO:0072539) |
| 2.9 |
8.7 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 2.9 |
8.6 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
| 2.8 |
19.3 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 1.7 |
5.0 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 1.6 |
9.6 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 1.6 |
7.8 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 1.6 |
6.2 |
GO:0032439 |
endosome localization(GO:0032439) |
| 1.3 |
2.7 |
GO:0060126 |
somatotropin secreting cell differentiation(GO:0060126) |
| 1.3 |
5.2 |
GO:1903416 |
negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) regulation of calcidiol 1-monooxygenase activity(GO:0060558) response to glycoside(GO:1903416) |
| 1.3 |
9.0 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 1.2 |
10.9 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 1.1 |
3.4 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 1.1 |
4.3 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 1.0 |
11.6 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.9 |
2.8 |
GO:0070093 |
negative regulation of glucagon secretion(GO:0070093) |
| 0.9 |
4.5 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 0.9 |
2.6 |
GO:0090135 |
actin filament branching(GO:0090135) negative regulation of phospholipase C activity(GO:1900275) |
| 0.8 |
4.1 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.8 |
1.6 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.8 |
3.0 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.8 |
6.8 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.8 |
3.8 |
GO:0019659 |
lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.7 |
1.5 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.7 |
4.4 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.7 |
1.4 |
GO:1905005 |
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 0.7 |
7.3 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.6 |
3.0 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.6 |
1.8 |
GO:0010911 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
| 0.6 |
5.3 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.6 |
10.6 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.5 |
9.9 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.5 |
4.9 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) |
| 0.5 |
1.5 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 0.5 |
2.9 |
GO:0046645 |
positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
| 0.4 |
2.2 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.4 |
2.3 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.4 |
7.7 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.4 |
12.5 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.3 |
1.0 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.3 |
4.8 |
GO:0090005 |
negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.3 |
1.3 |
GO:1902965 |
regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.3 |
1.9 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.3 |
1.2 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.3 |
3.7 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.3 |
1.2 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.3 |
0.9 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.3 |
1.4 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
| 0.3 |
1.1 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.3 |
0.8 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.3 |
4.2 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.3 |
0.8 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.2 |
1.5 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.2 |
1.4 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.2 |
1.5 |
GO:0051461 |
protein import into peroxisome matrix, docking(GO:0016560) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.2 |
6.5 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.2 |
3.8 |
GO:0090103 |
cochlea morphogenesis(GO:0090103) |
| 0.2 |
6.2 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.2 |
0.9 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.2 |
0.7 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.2 |
1.1 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.2 |
1.7 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.2 |
1.5 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.2 |
2.7 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.2 |
1.7 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.2 |
1.2 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.2 |
1.5 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.2 |
2.4 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.2 |
1.7 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.1 |
1.6 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
2.8 |
GO:0048730 |
epidermis morphogenesis(GO:0048730) |
| 0.1 |
1.8 |
GO:0045954 |
positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.1 |
0.4 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 |
7.7 |
GO:0048663 |
neuron fate commitment(GO:0048663) |
| 0.1 |
4.1 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.1 |
0.7 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.1 |
0.5 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) specification of axis polarity(GO:0065001) |
| 0.1 |
1.7 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.1 |
0.4 |
GO:0003097 |
renal water transport(GO:0003097) renal water absorption(GO:0070295) |
| 0.1 |
2.0 |
GO:0051573 |
negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.1 |
1.8 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.1 |
2.0 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.1 |
2.7 |
GO:0010883 |
regulation of lipid storage(GO:0010883) |
| 0.1 |
3.2 |
GO:0031365 |
N-terminal protein amino acid modification(GO:0031365) |
| 0.1 |
0.3 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 |
3.0 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 |
0.9 |
GO:0002536 |
respiratory burst involved in inflammatory response(GO:0002536) |
| 0.1 |
0.7 |
GO:0042559 |
pteridine-containing compound biosynthetic process(GO:0042559) |
| 0.1 |
0.4 |
GO:0052695 |
cellular glucuronidation(GO:0052695) |
| 0.1 |
3.3 |
GO:0042491 |
auditory receptor cell differentiation(GO:0042491) |
| 0.1 |
2.3 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.1 |
1.0 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 |
10.6 |
GO:0000910 |
cytokinesis(GO:0000910) |
| 0.1 |
5.8 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.1 |
2.4 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
1.8 |
GO:0043153 |
photoperiodism(GO:0009648) entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 |
0.4 |
GO:0006046 |
N-acetylglucosamine catabolic process(GO:0006046) |
| 0.1 |
1051.4 |
GO:0008150 |
biological_process(GO:0008150) |
